Inhibrx Biosciences, Inc. (INBX)

NASDAQ: INBX · Real-Time Price · USD

27.32

-1.13 (-3.97%)

At close: Sep 12, 2025, 4:00 PM EDT

27.52

+0.20 (0.73%)

After-hours: Sep 12, 2025, 4:57 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Biologic Therapeutics	1.80M	Log In
Biologic Therapeutics Growth	-17.88%	Log In

Revenue by Geography

Fiscal year is January - December.